![[I, Librarian]](https://www.bioinformatics.org/images/ack_banners/ILibrarian-728x90.png)
-
By Tim Powell and Alex Wilson
``Now that the dust is beginning to settle from the debate on the patentability of gene sequences, and as clearer principles are beginning to emerge from European and US patent regulators, a new hurdle for patent applicants has appeared: enforcement.
``With the advent of in silico research, traditional approaches to infringement are beginning to look outdated. In this installment of TrendSpotter, we look at the difficulties of using patents to restrict the in silico manipulation of genetic information.
``Patentability of gene sequences: The enormous number of patent applications filed by companies like Incyte, Celera Genomics, and Human Genome Sciences for their sequence data is beginning to trigger a steady flow of patents claiming ESTs and complete-gene sequences. The US Patent and Trademark Office has responded by introducing more stringent utility requirements to the point that applicants must now show a substantial, credible, and specific utility.''
Full story:
http://genomeweb.com/articles/view-article.asp?Article=2002628114940
![[Photo]](https://www.bioinformatics.org/images/photo.php?photo_id=5)
Discussion forums: GenomeWeb: In Silico Research: The Specter of Virtual Patent Infringement in Europe
Expanded view | Monitor forum | Save place
Comment
|
Iwant to do M.S.C from auniversity of South Africa in bioinformatics.I am now in B.S.C 1st year. my name is Miss Paushali Mukherjee. If there is any entrance examination, i want to prepare for that. If any subscribe is needed Iwill pay it.
|
Reply to this comment:
You have to be logged in to post a reply.
Thread view:
|
